Christopher G. Parker
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Google:
"Christopher Parker"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David A. Spiegel | grad student | 2007-2013 | Yale | |
| (Synthetic Approaches to Modulate Immune Responses: Development of Bifunctional Molecules that Target HIV and Related Studies.) | ||||
| Benjamin F. Cravatt | post-doc | 2013- | Scripps Institute | |
Children
Sign in to add trainee| Ines Forrest | grad student | 2020- | Scripps Research Institute |
| Appaso M Jadhav | post-doc | 2018- | Scripps Institute |
| Wesley W. Wang | post-doc | 2019- | Scripps Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vázquez-Villa H, Rueda-Zubiaurre A, Fernández D, et al. (2024) Chemical probes for the identification of the molecular targets of honokiol. European Journal of Medicinal Chemistry. 283: 117102 |
| Wozniak JM, Li W, Parker CG. (2024) Chemical proteomic mapping of reversible small molecule binding sites in native systems. Trends in Pharmacological Sciences |
| Chen LY, Singha Roy SJ, Jadhav AM, et al. (2024) Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules. Acs Chemical Biology |
| O'Brien JGK, Conway LP, Ramaraj PK, et al. (2024) Mechanistic differences between linear spirocyclic dialkyldiazirine probes for photoaffinity labeling. Chemical Science |
| Wozniak JM, Li W, Governa P, et al. (2024) Author Correction: Enhanced mapping of small-molecule binding sites in cells. Nature Chemical Biology |
| Chiu TY, Lazar DC, Wang WW, et al. (2024) Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity. Nature Chemical Biology |
| Wozniak JM, Li W, Governa P, et al. (2024) Enhanced mapping of small-molecule binding sites in cells. Nature Chemical Biology |
| Forrest I, Parker CG. (2023) Proteome-Wide Fragment-Based Ligand and Target Discovery. Israel Journal of Chemistry. 63 |
| Wichroski M, Benci J, Liu SQ, et al. (2023) DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity. Science Translational Medicine. 15: eadh1892 |
| Chen LY, Wang WW, Wozniak JM, et al. (2022) A heterobifunctional molecule system for targeted protein acetylation in cells. Methods in Enzymology. 681: 287-323 |